FDA Investigator Michelle J Glembin
Michelle J Glembin has inspections in 14 countries as of 05 Oct 2023. Michelle J Glembin has collaborated with a combined 3538 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
188
Last Inspection Date:
05 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Switzerland,
Ireland,
Austria,
Canada,
Costa Rica,
United Kingdom of Great Britain and Northern Ireland,
Hungary,
Mexico,
Germany,
Romania,
Netherlands,
Sweden,
Norway
Co-Investigator(s):
A Williams,
Aaron L Dunbar,
Adaliz Santaliz Cruz,
Adam J Taylor,
Akbar J Zaidi,
Albert L Nguyen,
Alecia L Marson,
Amir Alavi,
Amos,
Amy M Cramer,
Andrea A Branche,
Anthony L Nicoli,
Benjamin W Anderson,
Bill Tacket, Jr,
Billi Jom Johnson,
Bonnie E Pierson,
Boun M Xiong,
Brian S Keefer,
Candace S Tucker,
Carolyn E Barney,
Catherine J Laufmann,
Catherine M Vanderhoef,
CDR Sean T Creighton,
Charles N Dupont,
Charles R Cote, RIC,
Christina A Castineyra,
Christopher D Leach,
Claudette D Brooks,
Clifton L Randell,
Constance L Richard,
Constance Lrichard Math,
Corey K Reno,
Corey K Zelinski,
Cynthia A Harris, MD, RN,
Dale A Nyberg,
Daniel J Lahar,
Daniel L Aisen,
Dawn M Mccabe,
Denise L Burosh,
Diane T Reindl,
Dr. Barbara D Paul, PhD,
Dr. Nallaperumal Chidambaram,
Edward E Lockwood (EEL),
Edward J Janik,
Elizabeth E Hart (ASCP), MT,
Emily S Mcgann,
Emma R Schaefer,
Eric A Breselow,
Eric C Fox,
Eric M Padgett,
Evelyn Taha,
Felix J Marrero,
Frank J Marciniak,
Fulton A Varner,
George T Allen, Jr,
Gerald D Bromley, Jr,
Gisselle I Sensebe,
Gloria A Milster,
Gordon T Wales,
Gregson A Joseph,
Harperd,
Heather Akleimola Hulbert,
Helen B Ricalde,
Humera T Khan,
Jacqueline S Warner,
James A Beaulieu,
James Beaulieu,
James E Frye,
James L Finn,
James M Mason,
James P Mcreavey,
James W Plucinski,
James W Whitney,
Janis R Armedoriz,
Jason P Aun,
Javelle P Spann,
Jean M Bosenbecker,
Jeanne M Morris,
Jeffery A Hangartner,
Jeffry A Bernhardt,
Jennifer Al Vollon,
Jennifer Alongie Vollom,
Jennifer S Ness,
Jeremy W Rotton,
Jesse A Vazquez,
Jesse P Romenesko,
Jessica L Johnson,
Jocelyn M Muggli,
Joel D Hustedt,
John A Sciacchitano,
John P Hermann,
Jopseh M Edwin,
Joseph D Gong,
Joseph M Edwin,
Joseph R Strelnik,
Junho Pak,
Justin A Boyd,
Kaarin M Slotte,
Karen A Coleman,
Karen M Montgomery (KMM),
Karl D Hezel,
Kathleen B Swat,
Kathryn M Mogen,
Keith C Rindahl,
Kellie L Thommes, RN,
Kellie L Westerbuhr,
Kenneth A Libertoski,
Kevin L Torgerson,
Kevin N Tran,
Kia L Copeland,
Kim M Downing,
Kimberly Lewandowski Walker,
Kinh Q Mac,
Kyle J Mccracken,
Laiza V Garcia,
LCDR Matthew J Morrison,
Leeterry Moore,
Leon R Stratman,
Leonard H Lavi,
Linda V Weyer,
Lisa M Lopez,
Lisa T Michel,
Loretta Nemchik,
Lori A Carr,
Lori S Lawless,
Lydia S Chan,
Margaret M Annes,
Marissa S Steinhagen,
Mark E Chan,
Martina E Lagrange,
Mary Ann Ruff,
Mary K Concannon,
Melanie G Warzala,
Melanie W Pishnery,
Melissa D Kalik,
Melissa I Michurski,
Melissa J Holz,
Melissa J Ireland,
Miaja Umaedi,
Michael J Nerz,
Michael S Araneta,
Mildred J Tures,
Minh D Phan,
Nicholas T Domer,
Nicholas Z Lu,
Nicole C Shokatz,
Nicole C Victoria, PhD,
Patricia A Mcilroy,
Patrick J Campbell,
Paul E Stein,
Paul M Kawamoto,
Paul W Moy,
Pauline N Logan,
Perry H Gambrell,
Philip J Boston,
Rafael A Kaup,
Ralph Jerndal,
Rebecca L Mullikin,
Richard Jay Tucker, RS,
Richard K Vogel,
Richard W Koller,
Robert J Ham,
Robert J Nesselhauf,
Robert M Tillman,
Ronald R Ruff,
Ross J Grigsby,
Roy Baby,
Ruth Moore, PhD,
Saleem A Akhtar,
Sandra A Hughes,
Sandra Sejdinovic,
Sarah A Palmer,
Sargum C Morgan,
Scott B Laufenberg,
Scott L Schenian,
Seema S Singh,
Selene T Torres,
Shafiq S Ahadi,
Shalonda C Clifford,
Sharon K Thoma, PharmD,
Shererk,
State Agency,
Stephen C Smith,
Stephen D Eich,
Steven Fong, MS, PhD,
Steven M Weinman,
Susan D Yuscius,
Susan M Matthias,
Susan M Miller,
Susan M North,
Suzanne M Crotty,
Tara M Carolfi,
Tara M Humfeld,
Terry C Kimball,
Thomas S Donaldson,
Thomas W Garvin,
Tony T Yang,
Tyler R Courtney,
Walden H Lee,
Xiaojun Yan,
Yehualashet A Gessesse
Michelle J Glembin's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more